Clinical Trial Update: Weight Loss With Risedronate for Bone Health [Phase 4]

View source ↗

Summary

Phase 4 trial investigating weight loss effects of risedronate for bone health in bariatric surgery candidates; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery Candidate
• Bone Loss
• Obesity

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Bariatric Surgery Candidate, Bone Loss | Phase 4 | Status: COMPLETED | Results posted: 2021-01-22